Napo Therapeutics S.p.A.

Gastrointestinal Disorders

Napo Therapeutics S.p.A. focuses its clinical research on Short Bowel Syndrome with Intestinal Failure, particularly in adults living without colon-in-continuity. This area reflects a concentrated interest in severe intestinal malabsorption and related digestive complications.

  • Short Bowel Syndrome
  • Intestinal Failure
  • Colon-in-continuity

The sponsor’s work in this field addresses complex gastrointestinal conditions where restoration of fluid balance, nutrient absorption, and bowel function is clinically important.

Orphan and Rare Disease Care

The company’s research activity is centered on a rare, high-burden patient population with limited therapeutic options. Its clinical interest lies in conditions that require specialized management and long-term support.

  • Rare gastrointestinal disease
  • Adult patient population
  • Specialty care

This area aligns with the need for targeted treatment strategies in uncommon disorders affecting intestinal function and daily clinical management.

Symptom Control and Supportive Therapy

Clinical interest extends to managing the symptoms associated with SBS-IF, including excess intestinal output and related consequences of impaired absorption. The therapeutic focus is on improving tolerability and functional outcomes in patients with severe bowel loss.

  • Intestinal output reduction
  • Fluid and electrolyte balance
  • Digestive symptom management

These topics are relevant to patients whose nutritional and hydration needs remain difficult to manage in routine care.

Clinical Pharmacology in Gastroenterology

Napo Therapeutics is involved in evaluating a gastrointestinal therapeutic intended for adult patients with severe intestinal dysfunction. Its research interest includes treatment effects on safety, tolerability, and early signs of clinical benefit in a specialized digestive disorder.

  • Gastrointestinal therapeutics
  • Safety and tolerability
  • Preliminary efficacy

This places the sponsor within the development of medicines for complex disorders of bowel function and absorptive capacity.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Crofelemer for Adults with Short Bowel Syndrome and Intestinal Failure Without Colon in Continuity

    Recruiting

    Investigated diseases:
    Investigated drugs:
    Germany Italy